Sitagliptin/Metformin hydrochloride Sandoz Litvánia - litván - SMCA (Valstybinė vaistų kontrolės tarnyba)

sitagliptin/metformin hydrochloride sandoz

sandoz d.d. - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin

Sitagliptin/Metformin hydrochloride Grindeks Litvánia - litván - SMCA (Valstybinė vaistų kontrolės tarnyba)

sitagliptin/metformin hydrochloride grindeks

as grindeks - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and sitagliptin

Sitagliptin/Metformin hydrochloride Grindeks Litvánia - litván - SMCA (Valstybinė vaistų kontrolės tarnyba)

sitagliptin/metformin hydrochloride grindeks

as grindeks - sitagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and sitagliptin

Sitagliptin / Metformin hydrochloride Accord Európai Unió - litván - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , trigubas derinys terapija), kaip papildoma priemonė kartu su dieta ir fiziniais pratimais pacientams, nepakankamai kontroliuojama, jų maksimali toleruojama dozė metforminas ir sulfonilkarbamido dariniai. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin/Metformin hydrochloride ELVIM Litvánia - litván - SMCA (Valstybinė vaistų kontrolės tarnyba)

vildagliptin/metformin hydrochloride elvim

sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/850 mg - metformin and vildagliptin

Vildagliptin/Metformin hydrochloride ELVIM Litvánia - litván - SMCA (Valstybinė vaistų kontrolės tarnyba)

vildagliptin/metformin hydrochloride elvim

sia elvim - vildagliptinas/metformino hidrochloridas - plėvele dengtos tabletės - 50 mg/1000 mg - metformin and vildagliptin

Trevicta (previously Paliperidone Janssen) Európai Unió - litván - EMA (European Medicines Agency)

trevicta (previously paliperidone janssen)

janssen-cilag international nv - paliperidono palmitatas - Šizofrenija - psicholeptikai - trevicta, 3 mėnesio injekcija, skiriama šizofrenijos palaikomajam gydymui suaugusiems pacientams, kurie yra kliniškai stabilūs 1 mėnesio paliperidono palmitato injekciniu preparatu.

Byannli (previously Paliperidone Janssen-Cilag International) Európai Unió - litván - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidono palmitatas - Šizofrenija - psicholeptikai - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Európai Unió - litván - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).

Oxaliplatin Accord Litvánia - litván - SMCA (Valstybinė vaistų kontrolės tarnyba)

oxaliplatin accord

accord healthcare b.v. - oksaliplatina - koncentratas infuziniam tirpalui - 5 mg/ml - oxaliplatin